These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 12654259)

  • 41. Metronomic chemotherapy: Back to the future!
    André N; Padovani L; Verschuur A
    Drug News Perspect; 2010 Mar; 23(2):143-51. PubMed ID: 20369080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin.
    Herbst RS; Mullani NA; Davis DW; Hess KR; McConkey DJ; Charnsangavej C; O'Reilly MS; Kim HW; Baker C; Roach J; Ellis LM; Rashid A; Pluda J; Bucana C; Madden TL; Tran HT; Abbruzzese JL
    J Clin Oncol; 2002 Sep; 20(18):3804-14. PubMed ID: 12228200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synopsis of angiogenesis inhibitors in oncology.
    Ellis LM; Liu W; Fan F; Jung YD; Reinmuth N; Stoeltzing O; Takeda A; Akagi M; Parikh AA; Ahmad S
    Oncology (Williston Park); 2002 May; 16(5 Suppl 4):14-22. PubMed ID: 12102576
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells.
    Pasquier E; Honore S; Pourroy B; Jordan MA; Lehmann M; Briand C; Braguer D
    Cancer Res; 2005 Mar; 65(6):2433-40. PubMed ID: 15781659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
    Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
    Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis.
    El-Naa MM; Othman M; Younes S
    Drug Des Devel Ther; 2016; 10():3661-3672. PubMed ID: 27895461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antiangiogenic strategies on defense: on the possibility of blocking rebounds by the tumor vasculature after chemotherapy.
    Shaked Y; Kerbel RS
    Cancer Res; 2007 Aug; 67(15):7055-8. PubMed ID: 17671170
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Salinomycin exerts anti-angiogenic and anti-tumorigenic activities by inhibiting vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Li T; Liu X; Shen Q; Yang W; Huo Z; Liu Q; Jiao H; Chen J
    Oncotarget; 2016 May; 7(18):26580-92. PubMed ID: 27058891
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models.
    Ferguson D; Rodriguez LE; Palma JP; Refici M; Jarvis K; O'Connor J; Sullivan GM; Frost D; Marsh K; Bauch J; Zhang H; Lin NH; Rosenberg S; Sham HL; Joseph IB
    Clin Cancer Res; 2005 Apr; 11(8):3045-54. PubMed ID: 15837760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The selective class III/V receptor tyrosine kinase inhibitor SU11657 inhibits tumor growth and angiogenesis in experimental neuroblastomas grown in mice.
    Bäckman U; Christofferson R
    Pediatr Res; 2005 May; 57(5 Pt 1):690-5. PubMed ID: 15718357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Influence of formulation vehicle on metronomic taxane chemotherapy: albumin-bound versus cremophor EL-based paclitaxel.
    Ng SS; Sparreboom A; Shaked Y; Lee C; Man S; Desai N; Soon-Shiong P; Figg WD; Kerbel RS
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4331-8. PubMed ID: 16857808
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metronomic chemotherapy: A potent macerator of cancer by inducing angiogenesis suppression and antitumor immune activation.
    Biziota E; Mavroeidis L; Hatzimichael E; Pappas P
    Cancer Lett; 2017 Aug; 400():243-251. PubMed ID: 28017892
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy.
    Singh RP; Dhanalakshmi S; Agarwal C; Agarwal R
    Oncogene; 2005 Feb; 24(7):1188-202. PubMed ID: 15558015
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Propolis suppresses tumor angiogenesis by inducing apoptosis in tube-forming endothelial cells.
    Ohta T; Kunimasa K; Kobayashi T; Sakamoto M; Kaji K
    Biosci Biotechnol Biochem; 2008 Sep; 72(9):2436-40. PubMed ID: 18776674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Angiogenesis as a target for tumor treatment.
    Gastl G; Hermann T; Steurer M; Zmija J; Gunsilius E; Unger C; Kraft A
    Oncology; 1997; 54(3):177-84. PubMed ID: 9143396
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives.
    Samuel DP; Wen PY; Kieran MW
    Expert Opin Investig Drugs; 2009 Jul; 18(7):973-83. PubMed ID: 19548852
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Angiogenesis research: guidelines for translation to clinical application.
    Folkman J; Browder T; Palmblad J
    Thromb Haemost; 2001 Jul; 86(1):23-33. PubMed ID: 11487011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A paradigm for therapy-induced microenvironmental changes in solid tumors leading to drug resistance.
    Yu JL; Coomber BL; Kerbel RS
    Differentiation; 2002 Dec; 70(9-10):599-609. PubMed ID: 12492501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.
    Kong D; Okamura M; Yoshimi H; Yamori T
    Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiangiogenic chemotherapeutic agents.
    Schirner M
    Cancer Metastasis Rev; 2000; 19(1-2):67-73. PubMed ID: 11191065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.